1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 12 Hits
  • 検索条件 : 絞込み (MeSH = Enhancer of Zeste Homolog 2 Protein / genetics)
生物種 リソース名 タイトル
ヒト・動物細胞 TE-1(RCB1894) , TE-5(RCB1949) , TE-6(RCB1950) , TE-8(RCB2098) , TE-10(RCB2099) , TE-11(RCB2100) , TE-14(RCB2101) , TE-15(RCB1951) Genome-wide gain-of-function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma.
実験動物マウス RBRC02302 , RBRC05555 Less Severe Sepsis in Cecal Ligation and Puncture Models with and without Lipopolysaccharide in Mice with Conditional Ezh2-Deleted Macrophages (LysM-Cre System).
ヒト・動物細胞 HS-ES-1(RCB2364) , HS-ES-2M(RCB2360) , HS-ES-2R(RCB2361) Targeting dependency on a paralog pair of CBP/p300 against de-repression of KREMEN2 in SMARCB1-deficient cancers.
ヒト・動物細胞 ACC-MESO-1(RCB2292) Long Non-coding RNA LINC00152 Requires EZH2 to Promote Mesothelioma Cell Proliferation, Migration, and Invasion.
ヒト・動物細胞 HOUA-I(RCB0659) EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis.
遺伝子材料 , ヒト・動物細胞 CS-RfA-EVBsd (RDB06090) , pENTR4-H1 (RDB04395) , pCAG-HIVgp (RDB04394) , pCMV-VSV-G-RSV-Rev (RDB04393) , ATN-1(RCB1440) Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas.
ヒト・動物細胞 Jurkat Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation.
実験動物マウス , ヒト・動物細胞 RBRC05555 , TM-31(RCB1731) , T98G(RCB1954) Pathogenic Epigenetic Consequences of Genetic Alterations in IDH-Wild-Type Diffuse Astrocytic Gliomas.
ヒト・動物細胞 RBE(RCB1292) Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma.
ヒト・動物細胞 293(RCB1637) Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia.
ヒト・動物細胞 LC-2/ad(RCB0440) Epigenetic regulation of epithelial-mesenchymal transition by KDM6A histone demethylase in lung cancer cells.
ヒト・動物細胞 HS-SY-II(RCB2231) Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.